Related references
Note: Only part of the references are listed.Structure analysis of the receptor binding of 2019-nCoV
Yun Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis
Harvey A. Risch
AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
S. Gevers et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report
Kazuha Nakamura et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
Jahan S. Khalili et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
Anwar M. Hashem et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Covid-19 treatment update: follow the scientific evidence
Richard C. Becker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review
Boscolli Barbosa Pereira
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2020)
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
Praveen Tilangi et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19 and the impact of social determinants of health
Elissa M. Abrams et al.
LANCET RESPIRATORY MEDICINE (2020)
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
Lei Zha et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
RE: EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS REPLY
Harvey A. Risch
AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)
Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
Vincent Fleury
AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)
Type 1 interferons as a potential treatment against COVID-19
Erwan Sallard et al.
ANTIVIRAL RESEARCH (2020)
What is the role of rheumatologists in the era of COVID-19?
Daniela Marotto et al.
AUTOIMMUNITY REVIEWS (2020)
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy
Laurel C. Chandler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Roland Derwand et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
Brian Godman et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19
Pranab Chatterjee et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease
Yong Wah Tan et al.
ANTIVIRAL RESEARCH (2018)
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
Pierre Roques et al.
VIRUSES-BASEL (2018)
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li et al.
EBIOMEDICINE (2017)
New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
Payam Peymani et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients
Gouda Kamel Helal et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
The enigma of the clandestine association between chloroquine and HIV-1 infection
A. Chauhan et al.
HIV MEDICINE (2015)
Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
Stuart D. Dowall et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Chloroquine interferes with dengue-2 virus replication in U937 cells
Kleber Juvenal Silva Farias et al.
MICROBIOLOGY AND IMMUNOLOGY (2014)
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
Yiwu Yan et al.
CELL RESEARCH (2013)
Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
Juliana Cruz da Silva et al.
CLINICS (2013)
Chloroquine is effective against influenza A virus in vitro but not in vivo
David J. Vigerust et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2007)
Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes
C. -H. Jang et al.
RHEUMATOLOGY (2006)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Share Paper
